Stock listing
NASDAQ:MLTX MoonLake Immunotherapeutics Stock
Home listing (NASDAQ) of MoonLake Immunotherapeutics
Follow MoonLake Immunotherapeutics into a list and get an email when it puts out news.
Share price · NASDAQ:MLTX
$11.78 USD -0.79 (-6.3%)
Close on Oct 30, 2026
- Day range
- $11.71 – $12.63 USDOct 30, 2026
- Volume
- 1.12M sharesOct 30, 2026
- Market cap
- $1.00B USDAt the close on Oct 30, 2026 · price × 85.11M shares outstanding
- 52-week range
- $9.46 – $23.29 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $22.07M USDMedian day 1.37M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MLTX · Home | $11.78 USD | -0.79 (-6.3%) | 1,115,499 | $12.44 | $12.63 | $11.71 | $12.57 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:MLTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $11.78 | -0.79 | -6.3% | $12.44 | $12.63 | $11.71 | 1,115,499 | |
| $12.57 | +0.26 | +2.1% | $12.36 | $12.93 | $12.31 | 4,094,074 | |
| $12.31 | +0.38 | +3.2% | $11.87 | $12.38 | $11.71 | 1,196,553 | |
| $11.93 | +0.12 | +1.0% | $11.77 | $12.10 | $11.54 | 933,730 | |
| $11.81 | -0.04 | -0.3% | $11.82 | $12.45 | $11.67 | 1,511,233 | |
| $11.85 | -0.49 | -4.0% | $12.07 | $12.28 | $11.48 | 1,935,000 | |
| $12.34 | +1.69 | +15.9% | $10.70 | $13.33 | $10.65 | 6,116,200 | |
| $10.65 | +0.33 | +3.2% | $10.34 | $10.73 | $10.34 | 1,163,600 | |
| $10.32 | +0.57 | +5.8% | $9.77 | $10.48 | $9.731 | 1,237,700 | |
| $9.75 | +0.20 | +2.1% | $9.57 | $9.863 | $9.50 | 911,600 | |
| $9.55 | -0.71 | -6.9% | $10.34 | $10.34 | $9.46 | 1,380,800 | |
| $10.26 | +0.12 | +1.2% | $10.16 | $10.51 | $10.14 | 1,067,200 | |
| $10.14 | -0.27 | -2.6% | $10.30 | $10.65 | $10.01 | 1,772,800 | |
| $10.41 | -0.27 | -2.5% | $10.70 | $10.84 | $10.36 | 2,412,500 | |
| $10.68 | -0.14 | -1.3% | $10.82 | $11.00 | $10.66 | 1,206,900 | |
| $10.82 | +0.24 | +2.3% | $10.58 | $11.09 | $10.40 | 2,011,000 | |
| $10.58 | -0.19 | -1.8% | $10.75 | $10.80 | $10.00 | 3,717,300 | |
| $10.77 | -0.18 | -1.6% | $10.81 | $11.29 | $10.71 | 1,396,000 | |
| $10.95 | -0.43 | -3.8% | $11.50 | $11.50 | $10.91 | 3,051,100 | |
| $11.38 | -0.03 | -0.3% | $11.56 | $11.72 | $11.19 | 1,867,200 | |
| $11.41 | -0.06 | -0.5% | $11.64 | $11.65 | $11.03 | 1,827,800 | |
| $11.47 | -0.23 | -2.0% | $11.73 | $11.84 | $11.29 | 1,305,100 | |
| $11.70 | +0.25 | +2.2% | $11.52 | $12.00 | $11.39 | 1,994,400 | |
| $11.45 | -0.11 | -1.0% | $11.56 | $11.70 | $11.40 | 1,506,800 | |
| $11.56 | -0.48 | -4.0% | $12.04 | $12.04 | $11.53 | 1,656,900 | |
| $12.04 | -0.08 | -0.7% | $12.15 | $12.21 | $11.80 | 2,179,500 | |
| $12.12 | -0.78 | -6.0% | $12.69 | $12.83 | $12.04 | 1,901,500 | |
| $12.90 | -0.48 | -3.6% | $13.41 | $13.69 | $12.23 | 2,003,200 | |
| $13.38 | +0.83 | +6.6% | $12.73 | $13.44 | $12.54 | 2,362,000 | |
| $12.55 | +0.16 | +1.3% | $12.50 | $12.65 | $12.24 | 1,219,800 | |
| $12.39 | +0.04 | +0.3% | $12.28 | $12.50 | $12.09 | 1,803,100 | |
| $12.35 | -0.11 | -0.9% | $12.66 | $12.80 | $12.20 | 2,298,100 | |
| $12.46 | +0.26 | +2.1% | $12.29 | $12.51 | $11.88 | 2,599,700 | |
| $12.20 | -0.48 | -3.8% | $12.70 | $12.70 | $12.02 | 1,797,600 | |
| $12.68 | +0.17 | +1.4% | $12.56 | $13.00 | $12.22 | 2,331,800 | |
| $12.51 | -0.67 | -5.1% | $13.33 | $13.55 | $12.47 | 2,384,200 | |
| $13.18 | -0.54 | -3.9% | $13.58 | $13.62 | $13.12 | 1,221,600 | |
| $13.72 | -1.22 | -8.2% | $14.90 | $15.00 | $13.66 | 1,690,100 | |
| $14.94 | -0.07 | -0.5% | $14.80 | $15.43 | $14.69 | 1,464,800 | |
| $15.01 | -0.18 | -1.2% | $15.06 | $15.24 | $14.87 | 1,428,200 | |
| $15.19 | +0.13 | +0.9% | $15.08 | $15.45 | $14.98 | 841,900 | |
| $15.06 | -0.07 | -0.5% | $15.14 | $15.47 | $14.85 | 1,187,100 | |
| $15.13 | +0.08 | +0.5% | $14.99 | $15.31 | $14.83 | 662,500 | |
| $15.05 | +0.06 | +0.4% | $14.94 | $15.11 | $14.63 | 1,017,700 | |
| $14.99 | -0.54 | -3.5% | $15.60 | $15.77 | $14.97 | 699,900 | |
| $15.53 | -0.09 | -0.6% | $15.62 | $15.78 | $15.47 | 1,099,500 | |
| $15.62 | +0.06 | +0.4% | $15.50 | $15.77 | $15.34 | 1,000,300 | |
| $15.56 | +0.19 | +1.2% | $15.54 | $15.97 | $15.53 | 819,000 | |
| $15.37 | -0.39 | -2.5% | $15.68 | $15.69 | $15.23 | 1,138,100 | |
| $15.76 | -0.11 | -0.7% | $15.99 | $16.10 | $15.58 | 1,350,900 | |
| $15.87 | -0.87 | -5.2% | $16.53 | $16.74 | $15.55 | 1,367,700 | |
| $16.74 | +0.40 | +2.4% | $16.57 | $16.86 | $16.12 | 1,447,700 | |
| $16.34 | -0.01 | -0.1% | $16.36 | $16.65 | $16.14 | 825,600 | |
| $16.35 | -0.12 | -0.7% | $16.44 | $16.66 | $16.20 | 1,200,500 | |
| $16.47 | -0.03 | -0.2% | $16.31 | $16.67 | $16.30 | 981,600 | |
| $16.50 | -0.73 | -4.2% | $17.64 | $17.73 | $16.47 | 1,337,700 | |
| $17.23 | +0.64 | +3.9% | $16.91 | $17.40 | $16.78 | 2,913,600 | |
| $16.59 | -0.74 | -4.3% | $17.48 | $17.48 | $15.93 | 3,606,600 | |
| $17.33 | -0.93 | -5.1% | $17.24 | $17.77 | $16.51 | 3,475,800 | |
| $18.26 | +0.23 | +1.3% | $18.47 | $18.63 | $17.92 | 902,100 | |
| $18.03 | +0.48 | +2.7% | $17.58 | $18.25 | $17.58 | 624,700 | |
| $17.55 | -0.38 | -2.1% | $17.94 | $18.11 | $17.45 | 579,200 | |
| $17.93 | +0.53 | +3.0% | $17.61 | $17.98 | $17.27 | 793,200 | |
| $17.40 | -1.04 | -5.6% | $18.50 | $18.55 | $17.36 | 1,273,000 | |
| $18.44 | -0.55 | -2.9% | $18.94 | $18.96 | $18.37 | 791,800 | |
| $18.99 | +0.61 | +3.3% | $18.44 | $19.09 | $18.30 | 676,800 |
- Ticker
- NASDAQ:MLTX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Aug 10, 2026
MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results
Latest deck · Jun 22, 2026
Investor Day (June 2026)
Investor day · 43 slides
Calls
Replays
Moonlake Immunotherapeutics (NASDAQ:MLTX) Q4 2023 Earnings Call
Sun, Mar 10, 2024 · 12:00 PM ET
Watch Transcript
Latest news
MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results
Aug 10, 2026
Closed $17.33 (-5.1%) on Aug 10, 2026
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
Jun 23, 2026
Closed $20.00 (-5.7%) on Jun 24, 2026
MoonLake Immunotherapeutics Announces Proposed Public Offering
Jun 22, 2026
Closed $21.22 (-4.2%) on Jun 23, 2026
MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
Jun 21, 2026
Closed $22.16 (+15.4%) on Jun 22, 2026
MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results
May 10, 2026
Closed $18.84 (+10.4%) on May 11, 2026
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Mar 28, 2026
Closed $16.93 (-2.3%) on Mar 30, 2026
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Feb 22, 2026
Closed $18.68 (-0.5%) on Feb 23, 2026
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer
Feb 10, 2026
Closed $15.62 (-0.8%) on Feb 10, 2026
Issued by another party
MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day
Feb 2, 2026
Closed $15.79 (+0.8%) on Feb 2, 2026
MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day
Jan 8, 2026
Closed $14.34 (+27.0%) on Jan 8, 2026
Decks
Investor Day (June 2026)
Investor day · 43 slides · Jun 22, 2026
Investor Day (February 2026)
Investor day · 49 slides · Feb 23, 2026
Technical Presentation (2026)
Technical · 17 slides · 2026
SHSA 2025 (Symposium on Hidradenitis Suppurativa Advances)
Conference · 19 slides · October 2025
MoonLake Immunotherapeutics on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 12 in the last 12 months · 54 in all · newest Aug 10, 2026 · oldest 2021
- Calls
- 1 call with a replay · 1 with a transcript · latest Mar 10, 2024
- Decks
- 12 decks · latest Jun 22, 2026
Where MoonLake Immunotherapeutics is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MLTX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:MLTX | BOATS | United States | USD |
| BIVA:MLTXN | BIVA | Mexico | MXN |
| BMV:MLTXN | BMV | Mexico | MXN |
Log in to ask 6ix AI your own questions about MoonLake Immunotherapeutics.